Financial Statements — ARTV
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 | Q1
2025 | Q3
2024 | Q2
2024 |
|---|
| Cash & Equivalents | 301.45 | 20.96 | 25.51 | 28.47 | 30.40 | 55.88 | 34.25 |
| Short-term Investments | 47.94 | 65.83 | 97.46 | 113.90 | 135.56 | 90.75 | 12.31 |
| Accounts Receivable | -- | -- | -- | -- | -- | 0.57 | 0.57 |
| Total Current Assets | 352.28 | 88.74 | 129.52 | 149.07 | 170.00 | 150.57 | 49.75 |
| Property, Plant & Equipment | 5.67 | 6.22 | 6.98 | 6.89 | 7.06 | 6.86 | 7.32 |
| Total Non-current Assets* | 16.36 | 17.22 | 19.34 | 20.33 | 21.26 | 75.03 | 26.16 |
| Total Assets | 368.63 | 105.96 | 148.86 | 169.39 | 191.26 | 225.60 | 75.91 |
| Accounts Payable | 1.39 | 2.29 | 0.85 | 1.22 | 2.04 | 1.22 | 0.82 |
| Total Current Liabilities | 14.58 | 10.88 | 11.12 | 10.77 | 12.20 | 13.29 | 10.83 |
| Total Non-current Liabilities* | 6.55 | 7.23 | 8.52 | 9.58 | 10.28 | 11.31 | 39.77 |
| Total Liabilities | 21.13 | 18.11 | 19.64 | 20.35 | 22.48 | 24.60 | 50.60 |
| Retained Earnings | (379.07) | (354.06) | (309.78) | (288.25) | (266.99) | (230.59) | (213.12) |
| Total Stockholder Equity | 347.50 | 87.85 | 129.22 | 149.04 | 168.78 | 201.00 | (191.10) |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Total Revenue | -- | -- | -- | -- | -- | 0.25 | 1.78 | 26.66 | 3.50 |
| Research & Development | 21.93 | 19.31 | 16.99 | 17.63 | 17.86 | 17.05 | 13.32 | 13.52 | 12.33 |
| Selling, General & Admin | 4.97 | 5.12 | 4.94 | 5.26 | 4.95 | 5.12 | 4.95 | 4.81 | 3.86 |
| Total Operating Expenses | 26.89 | 24.43 | 21.93 | 22.90 | 22.81 | 22.17 | 18.27 | 18.34 | 16.19 |
| Operating Income | (26.89) | (24.43) | (21.93) | (22.90) | (22.81) | (22.17) | (18.27) | (18.33) | (16.19) |
| Net Income | (25.00) | (23.52) | (20.77) | (21.53) | (21.25) | (20.31) | (16.09) | (17.47) | (17.84) |
| Basic EPS | (0.63) | (0.95) | (0.85) | (0.88) | (0.87) | (0.83) | 1.35 | (0.92) | (22.00) |
| Diluted EPS | (0.63) | (0.95) | (0.85) | (0.88) | (0.87) | (0.83) | 1.35 | (0.92) | (22.00) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 | Q1
2025 | Q4
2024 | Q3
2024 | Q2
2024 |
|---|
| Operating Cash Flow | (20.35) | (20.95) | (14.73) | (19.20) | (22.98) | (19.84) | (14.65) | (11.61) | (28.77) |
| Capital Expenditures | 0.42 | 0.24 | 0.42 | 0.60 | 1.06 | 0.51 | 0.06 | 0.10 | 0.48 |
| Free Cash Flow* | (20.77) | (21.19) | (15.15) | (19.80) | (24.04) | (20.35) | (14.71) | (11.71) | (29.25) |
| Investing Cash Flow | 17.59 | 15.32 | 16.04 | 16.28 | 21.12 | 9.97 | (0.97) | (130.63) | 11.13 |
| Financing Cash Flow | 283.27 | (0.11) | (0.12) | (0.04) | (0.07) | 0.24 | (0.03) | 163.87 | (1.62) |
* Derived from reported values
